Nitric Oxide as a Potential Bridge Between the Metabolic and Vascular Hypotheses of Diabetic Neuropathy
dc.contributor.author | Stevens, Martin J. | en_US |
dc.date.accessioned | 2010-06-01T21:09:30Z | |
dc.date.available | 2010-06-01T21:09:30Z | |
dc.date.issued | 1995-04 | en_US |
dc.identifier.citation | Stevens, M.J. (1995). "Nitric Oxide as a Potential Bridge Between the Metabolic and Vascular Hypotheses of Diabetic Neuropathy." Diabetic Medicine 12(4): 292-295. <http://hdl.handle.net/2027.42/74240> | en_US |
dc.identifier.issn | 0742-3071 | en_US |
dc.identifier.issn | 1464-5491 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/74240 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=7600740&dopt=citation | en_US |
dc.format.extent | 365089 bytes | |
dc.format.extent | 3109 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.publisher | Blackwell Publishing Ltd | en_US |
dc.rights | 1995 Diabetes UK | en_US |
dc.subject.other | Diabetic Neuropathy | en_US |
dc.subject.other | Nitric Oxide | en_US |
dc.subject.other | Aldose-reductase Inhibition | en_US |
dc.title | Nitric Oxide as a Potential Bridge Between the Metabolic and Vascular Hypotheses of Diabetic Neuropathy | en_US |
dc.type | Article | en_US |
dc.subject.hlbsecondlevel | Medicine (General) | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Department of Internal Medicine, and the Michigan Diabetes Research and Training Center, University of Michigan, Ann Arbor, USA | en_US |
dc.identifier.pmid | 7600740 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/74240/1/j.1464-5491.1995.tb00478.x.pdf | |
dc.identifier.doi | 10.1111/j.1464-5491.1995.tb00478.x | en_US |
dc.identifier.source | Diabetic Medicine | en_US |
dc.identifier.citedreference | Cameron NE, Cotter MA, Low PA. Nerve blood flow in early experimental diabetes in rats: relation to conduction defects. Am J Physiol 1991; 261: E1 – E8. | en_US |
dc.identifier.citedreference | Cameron NE, Cotter MA, Robertson S.. Angiotensin converting enzyme inhibition prevents development of muscle and nerve dysfunction and stimulated angiogenesis in streptozotocin-diabetic rats. Diabetologia 1992; 35: 12 – 18. | en_US |
dc.identifier.citedreference | Yasuda H., Sonobe M., Yamashita M., Terada M., Hatanaka I., Huitian Z., et al., Effect of prostaglandin E 1 analogue TFC 612 on diabetic neuropathy in streptozocin-induced diabetic rats: comparison with aldose reductase inhibitor ONO 2235. Diabetes 1989; 38: 832 – 838. | en_US |
dc.identifier.citedreference | Cameron NE, Cotter MA. Impaired contraction and relaxation in aorta from streptozotocin-diabetic rats: role of polyol pathway. Diabetologia 1992; 35: 1011 – 1019. | en_US |
dc.identifier.citedreference | Greene DA, Sima AAF, Stevens MJ, Feldman EL, Killen PD, Henry DN, et al., Aldose reductase inhibitors: An approach to the treatment of diabetic nerve damage. Diabetes Metabolism Reviews 1993; 9: 189 – 217. | en_US |
dc.identifier.citedreference | Zhu X. and Eichberg J.. 1,2-Diacylglycerol content and its arachidonyl-containing molecular species are reduced in sciatic nerve from streptozotocin-induced diabetic rats. J Neurochem 1990B; 55: 1087 – 1090. | en_US |
dc.identifier.citedreference | Kim J., Rushovich EH, Thomas TP, Ueda T., Agranoff BW, Greene DA. Diminished specific activity of cytosolic protein kinase C in sciatic nerve of streptozotocin-diabetic rats, and its correction by dietary myo-inositol. Diabetes 1991; 40: 1545 – 1554. | en_US |
dc.identifier.citedreference | Inoguchi T., Battan R., Handler E., Sportsman JR, Heath W., King GL. Preferential elevation of protein kinase C isoform bll and diacylglycerol levels in the aorta and heart of diabetic rats. Proc Natl Acad Sci USA 1992; 89: 11059 – 11063. | en_US |
dc.identifier.citedreference | Thomas TP, Feldman EL, Nakamura J., Kato K., Lien M., Stevens MJ, et al., Ambient glucose and aldose reductase-induced myo-inositol depletion modulate basal and carbachol-stimulated phosphoinositide metabolism and diacylglycerol accumulation in human retinal pigment epithelial cells in culture. Proc Natl Acad Sci USA 1993; 90: 9712 – 9716. | en_US |
dc.identifier.citedreference | Moncada S., Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 1991; 43: 109 – 141. | en_US |
dc.identifier.citedreference | Garthwaite J.. Glutamate, nitric oxide and cell-cell signalling in the nervous system. Trends Neurosci 1991; 14: 60 – 67. | en_US |
dc.identifier.citedreference | Stevens MJ, Dananberg J., Feldman EL, Lattimer SA, Kamijo M., Thomas TP, et al., The linked roles of nitric oxide, aldose reductase and (NA+, K+)-ATPase in the slowing of nerve conduction in the streptozotocin diabetic rat. J Clin Invest 1994; 94: 853 – 859. | en_US |
dc.identifier.citedreference | Greene DA, Lattimer SA. Impaired rat sciatic nerve sodium-potassium adenosine trisphosphatase in acute streptozotocin diabetes and its correction by dietary myo-inositol supplementation. J Clin Invest 1983; 72: 1058 – 1063. | en_US |
dc.identifier.citedreference | Greene DA, Lattimer SA, Sima AAF. Sorbitol, phosphoinositides, and sodium-potassium-ATPase in the pathogenesis of diabetic complications. N Engl J Med 1987; 316: 599 – 606. | en_US |
dc.identifier.citedreference | Gupta S., Sussman I., McArthur CS, Tornheim K., Cohen RA, Ruderman NB. Endothelium-dependent inhibition of Na/K-ATPase activity in rabbit aorta by hyperglycemia. J Clin Invest 1992; 90: 727 – 732. | en_US |
dc.identifier.citedreference | Bredt DS, Snyder SH. Isolation of nitric oxide synthase, a calmodulin-requiring enzyme. Proc Natl Acad Sci 1990; 87: 682 – 685. | en_US |
dc.identifier.citedreference | Bredt DS, Ferris CD. Synder SH. Nitric oxide synthetase regulatory sites. J Biol Chem 1992; 267: 10976 – 10981. | en_US |
dc.identifier.citedreference | Nakane M., Mitchel L., Forstermann U., Murad F.. Phosphorylation by calcium calmodulin-dependent protein kinase II and protein kinase C modulates the activity of nitric oxide synthetase. Biochem Biophys Res Commun 1991; 180: 1396 – 1402. | en_US |
dc.identifier.citedreference | Murthy KS, Jin J.-G, Makhlouf GM. Inhibition of nitric oxide synthase activity in dispersed gastric muscle cells by protein kinase C. Am J Physiol 1994; 266: G161 – G165. | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.